- A study showed people with mononucleosis are about three times more likely to develop MS than those without
- Epstein-Barr virus (EBV), the cause of mono, infects most adults globally and may trigger MS in some
- Mono symptoms include fatigue, fever, sore throat, and swollen lymph nodes, lasting several weeks
Most people think of infectious mononucleosis, commonly called "mono", as a temporary illness marked by fatigue, fever, and a sore throat. Often dubbed the "kissing disease," it is widely considered a short-lived viral infection that resolves with rest and basic care. However, new research is shifting this perception by linking mono to a more serious, long-term neurological condition, multiple sclerosis (MS). A recent study published in Neurology Open Access suggests that individuals who have had mono may face a significantly higher risk of developing MS later in life. While earlier research has hinted at a connection between viral infections and autoimmune diseases, this study adds stronger evidence to the growing body of work surrounding the Epstein-Barr virus (EBV), the primary cause of mono.
Given that EBV infects a vast majority of the global population, understanding its long-term health implications is critical. Importantly, experts emphasise that this association does not mean mono directly causes MS, but it may act as a trigger in susceptible individuals. This emerging insight not only deepens our understanding of MS but also highlights the importance of recognising and managing viral infections more carefully.
What The New Study Reveals
The study found that people who had infectious mononucleosis were about three times more likely to develop multiple sclerosis compared to those who had not been infected. Researchers analysed over 20 years of health data involving thousands of individuals with confirmed Epstein-Barr virus infection. Among those with a history of mono, 0.17% developed MS, compared to 0.07% in those without mono, indicating a significantly higher incidence rate.
However, scientists caution that the findings show an association, not direct causation. "Preventing these infections could reduce the overall burden of MS," noted researchers, highlighting the need for further investigation into EBV prevention strategies.
Understanding The EBV-MS Connection
Epstein-Barr virus is one of the most common human viruses, infecting up to 90-95% of adults globally. While many infections are asymptomatic, EBV can cause mono when contracted during adolescence or adulthood.
Growing evidence suggests EBV plays a critical role in MS development. A landmark long-term study found that EBV infection increased MS risk by as much as 32 times, making it the strongest known risk factor. Scientists believe this may be due to a phenomenon called "molecular mimicry," where the immune system mistakenly attacks the body's own nerve cells after fighting the virus.
Symptoms Of Mono You Should Not Ignore
Mono symptoms can range from mild to severe and typically appear 4-6 weeks after infection. Common signs include:
- Extreme fatigue
- Fever
- Sore throat
- Swollen lymph nodes (especially in the neck)
- Enlarged spleen
- Headache and body aches
These symptoms may persist for weeks, and fatigue can last even longer, affecting daily functioning.
Risk Factors For Mono And Severe Outcomes
While EBV infection is widespread, certain factors increase the likelihood of developing symptomatic mono or complications:
- Age: Teenagers and young adults are more likely to develop mono symptoms
- Weakened immunity: People with compromised immune systems may experience more severe illness
- Close contact: EBV spreads through saliva, increasing risk in shared living spaces
- Additionally, genetic susceptibility and immune response differences may determine whether EBV leads to long-term complications like MS.
What Increases MS Risk?
Multiple sclerosis is a complex autoimmune disease where the immune system attacks the protective myelin sheath of nerve cells. Beyond EBV infection, several factors contribute to MS risk:
- Genetic predisposition
- Low vitamin D levels
- Smoking
- Obesity
- Environmental exposures
Notably, MS is more common in women and typically develops between ages 20 and 50.
Treatment And Management Of Mono
There is no specific antiviral cure for mono, and treatment mainly focuses on relieving symptoms:
- Rest: Essential for recovery and immune function
- Hydration: Helps manage fever and fatigue
- Pain relievers: For sore throat and body aches
- Avoiding contact sports: To prevent spleen rupture
In most cases, people recover fully within weeks. However, prolonged fatigue and complications may require medical attention.
Why This Research Matters
This study reinforces the growing recognition of infections as potential triggers for chronic diseases. While most people infected with EBV will never develop MS, understanding this link could open doors to preventive strategies, including vaccines or early interventions. Emerging therapies, including experimental antibodies targeting EBV, are already being explored as a way to reduce long-term risks.
The link between mono and multiple sclerosis marks a significant shift in how scientists understand the long-term effects of common viral infections. While mono is often dismissed as a temporary illness, this new research suggests it may have deeper implications for neurological health.
Importantly, having mono does not mean a person will develop MS. However, the findings highlight the need for awareness, early diagnosis, and continued research into preventive strategies. As science continues to uncover the hidden impacts of viruses like EBV, individuals and healthcare systems alike may need to rethink how such infections are managed and monitored over time.
Disclaimer: This content, including advice, provides generic information only. It is in no way a substitute for a qualified medical opinion. Always consult a specialist or your own doctor for more information. NDTV does not claim responsibility for this information.
